Evaluation of the Effect of Drug-Related Problems in Pulmonary Embolism

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

January 15, 2023

Study Completion Date

January 15, 2023

Conditions
Pulmonary Thromboembolisms
Interventions
BEHAVIORAL

Intervention Group: Group to which the clinical pharmacist makes recommendations

The drugs administered to patients during scheduled hospital visits will be recorded. A detailed medication review will be conducted by the clinical pharmacist. As a result of a comprehensive evaluation, recommendations were made to doctors regarding drug-related problems and were recorded.

Trial Locations (1)

34093

Bezmialem Vakif University, Istanbul

All Listed Sponsors
collaborator

Istanbul University - Cerrahpasa

OTHER

collaborator

Istanbul Sultanbeyli State Hospital

OTHER_GOV

collaborator

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

OTHER

lead

Bezmialem Vakif University

OTHER